Filtros : "McGuire, P. K." "FMRP-RNC" Limpar

Filtros



Refine with date range


  • Source: Psychological Medicine. Unidade: FMRP

    Subjects: CANNABIS (COMPONENTES), IMAGEM POR RESSONÂNCIA MAGNÉTICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BHATTACHARYYA, S. et al. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control. Psychological Medicine, v. 44, n. 15, p. 3315-3328, 2014Tradução . . Disponível em: https://doi.org/10.1017/S0033291714000920. Acesso em: 30 set. 2024.
    • APA

      Bhattacharyya, S., Iyegbe, C., Atakan, Z., Martin-Santos, R., Crippa, J. A. de S., Xu, X., et al. (2014). Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control. Psychological Medicine, 44( 15), 3315-3328. doi:10.1017/S0033291714000920
    • NLM

      Bhattacharyya S, Iyegbe C, Atakan Z, Martin-Santos R, Crippa JA de S, Xu X, Williams S, Brammer M, Rubia K, Prata D, Collier DA, McGuire PK. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control [Internet]. Psychological Medicine. 2014 ; 44( 15): 3315-3328.[citado 2024 set. 30 ] Available from: https://doi.org/10.1017/S0033291714000920
    • Vancouver

      Bhattacharyya S, Iyegbe C, Atakan Z, Martin-Santos R, Crippa JA de S, Xu X, Williams S, Brammer M, Rubia K, Prata D, Collier DA, McGuire PK. Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control [Internet]. Psychological Medicine. 2014 ; 44( 15): 3315-3328.[citado 2024 set. 30 ] Available from: https://doi.org/10.1017/S0033291714000920
  • Source: Current Phamaceutical Design. Unidade: FMRP

    Subjects: CANNABIS (EFEITOS), FARMACOLOGIA, ANSIEDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARTÍN-SANTOS, R. et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers. Current Phamaceutical Design, v. 18, n. 32, p. 4966-4979, 2012Tradução . . Disponível em: https://doi.org/10.2174/138161212802884780. Acesso em: 30 set. 2024.
    • APA

      Martín-Santos, R., Crippa, J. A. de S., Batalla, A., Bhattacharyya, S., Atakan, Z., Borgwardt, S., et al. (2012). Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers. Current Phamaceutical Design, 18( 32), 4966-4979. doi:10.2174/138161212802884780
    • NLM

      Martín-Santos R, Crippa JA de S, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Faré M, Zuardi AW, McGuire PK. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 4966-4979.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/138161212802884780
    • Vancouver

      Martín-Santos R, Crippa JA de S, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S, Allen P, Seal M, Langohr K, Faré M, Zuardi AW, McGuire PK. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) administration in healthy volunteers [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 4966-4979.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/138161212802884780

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024